Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany

Pharmacy World and Science

Volumn 32, Issue 5, 2010, Pages 566-574

  Fiss, Thomas ^a   Ritter, Christoph Alexander ^a   Alte, Dietrich ^a   Van Den Berg, Neeltje ^a   Hoffmann, Wolfgang ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Adverse drug event; Drug interactions; Drug utilization review; Germany; Health professional network; Medication non adherence; Self medication

Indexed keywords

AGED; ARTICLE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DRUG INFORMATION; DRUG MONITORING; DRUG USE; FEASIBILITY STUDY; GENERAL PRACTITIONER; GERMANY; HEALTH DISPARITY; HOME CARE; HUMAN; INTERDISCIPLINARY RESEARCH; MEDICAL DOCUMENTATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACIST ATTITUDE; PRIMARY MEDICAL CARE; RURAL AREA;

AGED; AGED, 80 AND OVER; DELEGATION, PROFESSIONAL; DELIVERY OF HEALTH CARE; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; FEASIBILITY STUDIES; FEMALE; GERMANY; HOME CARE SERVICES; HOMEBOUND PERSONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ERRORS; PATIENT CARE TEAM; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACEUTICAL PREPARATIONS; PRACTICE MANAGEMENT, MEDICAL; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RURAL HEALTH SERVICES;

EID: 78349306848     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9409-6     Document Type: Article

References (39)

1. K Fendrich W Hoffmann 2007 More than just aging societies: the demographic change has an impact on actual numbers of patients J Public Health 15 345 351 10.1007/s10389-007-0142-0 (Pubitemid 47479584)
2. Gerlach F, Kuhlmey A, Glaeske G, Rosenbrock R, Wille E, Haubitz M et al. Koordination und Integration-Gesundheitsversorgung in einer Gesellschaft des längeren Lebens. Sondergutachten des Sachverständigenrates zur Begutachtung der Entwicklung im Gesundheitswesen 2009 (Coordination and integration-health care supply in an ageing society. Expert opinion of the expert advisory board of the German health care system). 2009. http://www.svr-gesundheit.de/Gutachten/Uebersicht/GA2009-LF.pdf. Accessed June 2010.
3. U Laaser J Breckenkamp 2006 Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol Eur J Public Health 16 217 222 10.1093/eurpub/cki062 16093306
4. Statistisches Landesamt Mecklenburg-Vorpommern. Statistisches Jahrbuch Mecklenburg-Vorpommern 2005 (Statistical yearbook Mecklenburg-Western Pomerania 2005). 1st ed. Schwerin: cw Obotritendruck GmbH; 2005. ISBN 3931654184.
5. T Kopetsch 2004 The medical profession in Germany: past trends, current state and future prospects Cah Sociol Demogr Med 44 43 70 15146658
6. T Kopetsch 2004 Ärztemangel in Deutschland und Mecklenburg- Vorpommern (lack of doctors in Mecklenburg-Western Pomerania) Ärztebl Mecklenbg Vorpommern 2004 41 48
7. V Bergk C Gasse D Rothenbacher M Loew H Brenner WE Haefeli 2004 Drug interactions in primary care: impact of a new algorithm on risk determination Clin Pharmacol Ther 76 85 96 1:CAS:528:DC%2BD2cXlsVaqt74%3D 10.1016/j.clpt.2004. 02.009 15229467 (Pubitemid 38844737)
8. K Fattinger M Roos P Vergeres C Holenstein B Kind U Masche, et al. 2000 Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine Br J Clin Pharmacol 49 158 167 1:CAS:528:DC%2BD3cXht1altL0%3D 10.1046/j.1365-2125.2000.00132.x 10671911 (Pubitemid 30068294)
9. CA Jankel LK Fitterman 1993 Epidemiology of drug-drug interactions as a cause of hospital admissions Drug Saf 9 51 59 1:STN:280:DyaK3szkvFCgtQ%3D%3D 10.2165/00002018-199309010-00005 8347291
10. SL Kane-Gill JW Devlin 2006 Adverse drug event reporting in intensive care units: a survey of current practices Ann Pharmacother 40 1267 1273 10.1345/aph.1H088 16849619 (Pubitemid 44204955)
11. AJ Leendertse AC Egberts LJ Stoker PM van den Bemt 2008 Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands Arch Intern Med 168 1890 1896 10.1001/archinternmed.2008.3 18809816
12. TJ Moore MR Cohen CD Furberg 2007 Serious adverse drug events reported to the Food and Drug Administration, 1998-2005 Arch Intern Med 167 1752 1759 10.1001/archinte.167.16.1752 17846394 (Pubitemid 47403063)
13. M Schaefer 2002 Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc Pharm World Sci 24 120 127 10.1023/A:1019543029936 12227243 (Pubitemid 34951309)
14. N van den Berg S Kleinke R Heymann RF Oppermann B Jakobi W Hoffmann 2009 Transfer of the AGnES concept to the regular German health-care system: legal evaluation, reimbursement, qualification Gesundhswes 72 285 292 10.1055/s-0029-1233472
15. N van den Berg C Meinke R Heymann T Fiss E Suckert C Pöller, et al. 2009 AGnES: Hausarztunterstützung durch qualifizierte Praxismitarbeiter (AGnES: supporting general practitioners with qualified medical practice personnel) Dtsch Arztebl Int 106 3 9 19564978
16. N van den Berg T Fiss C Meinke R Heymann S Scriba W Hoffmann 2009 GP-support by means of AGnES-practice assistants and the use of telecare devices in a sparsely populated region in Northern Germany-proof of concept BMC Fam Pract 44 1 8
17. T Fiss C Ritter W Hofmann 2007 Neues Konzept zur ambulanten pharmazeutischen Betreuung (New concept for ambulatory pharmaceutical care) Dtsch Apoth Ztg 147 2771 2772
18. C Terschüren K Fendrich N van den Berg W Hoffmann 2007 Implementing telemonitoring in the daily routine of a GP practice in a rural setting in northern Germany J Telemed Telecare 13 197 201 10.1258/135763307780908003 17565776
19. Schaefer M, Schulz M, Emmermann A, Mühlbauer K, Verheyen F. Manuale zur Pharmazeutischen Betreuung-Band 1: Grundlagen der Pharmazeutischen Betreuung (Manual for pharmaceutical care-basic principle of pharmaceutical care). ABDA-Bundesvereinigung Deutscher Apotheker GOVI-Verlag Eschborn; 2000. ISBN 9783774108448.
20. JW van Mil LO Westerlund KE Hersberger MA Schaefer 2004 Drug-related problem classification systems Ann Pharmacother 38 859 867 10.1345/aph.1D182 15054145 (Pubitemid 38509068)
21. A Gerdemann N Griese M Schulz 2007 Der Interaktions-Check in der Apotheke (The check for drug-drug-interactions in the community pharmacy) Pharm Ztg 152 3522 3524
22. Zagermann-Muncke P ABDA-Datenbank: Welche Interaktionen werden aufgenommen? (The ABDA-database: which drug-drug-interactions get included?). Pharm Ztg 2003. http://www.webcitation.org/5nlBwHRFk. Accessed June 2010.
23. P Zagermann-Muncke 2009 ABDA-Datenbank als Wegweiser im Wechselwirkungsdschungel (The ABDA-database) Pharm Ztg 154 26 28
24. N Muehlberger S Schneeweiss J Hasford 1997 Adverse drug reaction monitoring-cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions Pharmacoepidemiol Drug Saf 6 Suppl 3 S71 S77 10.1002/(SICI)1099-1557(199710)6:3+3.3.CO;2-9 15073757
25. ATC/DDD-ROM. Anatomic-therapeutic-chemical classification with DDD for German marked. GKV Drug index. Data status: May 2008. http://www.dimdi.de/ static/en/amg/atcddd/index.htm. Accessed June 2010.
26. American Society of Hospital Pharmacists 1993 ASHP statement on pharmaceutical care Am J Hosp Pharm 50 1720 1723
27. American Society of Health System Pharmacists. Survey reveals patient concerns about medication-related issues. http://www.webcitation.org/5iPNvMLob. Accessed June 2010.
28. Australian Association of Consultant Pharmacy. The facts on accreditation and remuneration for medication reviews-fact sheet no.2. http://www. webcitation.org/5iQfRIxmH. Accessed June 2010.
29. Emerson L Implementing home medication reviews in Australia: experience to date. ABDA-Bundesvereinigung Deutscher Apothekerverbände. 2009. http://www.webcitation.org/5iR0qDpV8. Accessed June 2010.
30. E Roughead N Pratt R Peck A Gilbert 2007 Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners Pharmacoepidemiol Drug Saf 16 797 803 10.1002/pds.1393 17476702 (Pubitemid 47180369)
31. SM Sawyer 2002 Action plans, self-monitoring and adherence: changing behaviour to promote better self-management Med J Aust 177 Suppl S72 S74 12225267
32. AK Bhuiyan 2004 Home medication review. A personal experience in rural Tasmania Aust Fam Physician 33 644 15373385
33. MS Roberts JA Stokes MA King TA Lynne DM Purdie PP Glasziou, et al. 2001 Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes Br J Clin Pharmacol 51 257 265 1:STN:280: DC%2BD3M3gvV2mug%3D%3D 10.1046/j.1365-2125.2001.00347.x 11298072 (Pubitemid 32396417)
34. DR Petty AG Zermansky DK Raynor 2001 Evidence shows medication reviews by pharmacists point way forward Pharm J 267 863 864
35. AG Zermansky DP Alldred DR Petty DK Raynor N Freemantle J Eastaugh, et al. 2006 Clinical medication review by a pharmacist of elderly people living in care homes-randomised controlled trial Age Ageing 35 586 591 10.1093/ageing/afl075 16905764 (Pubitemid 44614153)
36. M Pacini RD Smith EC Wilson R Holland 2007 Home-based medication review in older people: is it cost effective? Pharmacoecon 25 171 180 10.2165/00019053-200725020-00008 (Pubitemid 46175552)
37. R Beitz M Dören H Knopf HU Melchert 2004 Self-medication with over-the-counter (OTC) preparations in Germany Bundesgesundhsbl Gesundhsforsch Gesundhsschutz 47 1043 1050 1:STN:280:DC%2BD2crnvFSmtg%3D%3D 10.1007/s00103-004-0923-3
38. Bullinger M, Kirchberger I SF-36 Fragenbogen zum Gesundheitszustand (SF-36 Questionnaire about health related quality of life). 1998. http://www.webcitation.org/5qKWnBczF. Accessed June 2010.
39. NM Kheir JW van Mil JP Shaw JL Sheridan 2004 Health-related quality of life measurement in pharmaceutical care. Targeting an outcome that matters Pharm World Sci 26 125 128 10.1023/B:PHAR.0000026811.37414.4f 15230357 (Pubitemid 39012577)